Acta Pharmaciae Indonesia upholds the highest standards of academic integrity and originality. The journal requires all authors to meticulously adhere to international standards for academic integrity, particularly concerning plagiarism.

All submitted manuscripts are screened for plagiarism using reliable detection software such as Turnitin or iThenticate. Manuscripts with a similarity index exceeding 20% (excluding references, quotations, and legal texts) will be returned to the authors for revision.

To ensure the quality and authenticity of submitted manuscripts, the journal enforces a strict plagiarism policy. Plagiarism includes using another person's words, ideas, or data without proper acknowledgment. This encompasses, but is not limited to:
• Plagiarism of Ideas: Appropriating someone else's idea (e.g., an explanation, theory, conclusion, hypothesis, or metaphor) in whole or in part, or with superficial modifications, without crediting its originator.
• Plagiarism of Text: Copying a portion of text from another source without appropriate credit to its author.
• Inappropriate Paraphrasing: Taking portions of text from one or more sources, crediting the author(s), but only making 'cosmetic' changes to the borrowed material (e.g., changing a few words, rearranging the order, altering voice or tense). This is not considered proper paraphrasing.
• Self-Plagiarism: Reusing one's own previously disseminated content and presenting it as new without informing the reader of its prior appearance, thereby misleading the reader about the material's novelty.
• Duplicate (Dual) Publication: Submitting a paper with identical or nearly identical content to more than one journal without alerting the editors or readers to the existence of an earlier published version.
• Other Questionable Writing Practices: Neglecting to indicate the author's source of funding, failing to identify a possible conflict of interest, or establishing honorary authorship.

Should any type of plagiarism be found in a submitted manuscript, the paper will be rejected, and the author will be suspended for a minimum of one year. In cases of questionable writing practices, the paper will be returned to the author(s) with a request for revision.